The Effect of Education Given to Primiparous Pregnant Women on Parental Self-Efficacy and Mother-Infant Attachment

NCT ID: NCT04897906

Last Updated: 2023-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-12

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research will be carried out in a quasi-experimental design to determine the effect of maternity care and neonatal care training given to primiparous pregnant women on parental self-efficacy and mother-infant attachment in the postpartum period.

Research Hypotheses:

H0: There is no difference in parental self-efficacy and mother-infant attachment in the postpartum period between pregnant women who received training during pregnancy and did not.

H1: There is a difference in parental self-efficacy and mother-infant attachment in the postpartum period between pregnant women who received and did not receive education during pregnancy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The number of people to be included in the study was made with the power analysis made considering the previous studies. With the G \* Power (3.1.9.7.) Program, the number of samples for each group was determined as n = 34 at 80% power, 5% error and 95% confidence interval. Considering the losses in data collection, 20% was added to each group and it was decided to recruit a total of 80 people, 40 people for the experimental group and 40 people for the control group.

Pregnant women included in the research sample will be divided into two groups as experimental and control groups. Data will be collected by sending via an online questionnaire created by the researchers. Before the online questionnaire is sent to the experimental and control groups, the experimental-control days will be determined randomly by a lottery drawn by a third person (blinding). Pregnant women who agree to participate in the study will be assigned to the experimental and control groups according to the determined days.

The data obtained in the study will be analyzed using the SPSS (Statistical Package for Social Sciences) for Windows 22.0 program. Significance value will be considered as p \<0.05.

Number, percentage, mean and standard deviation will be used as descriptive statistical methods in the evaluation of data. Pearson correlation and regression analysis will be applied among the continuous variables of the study. The t-test will be used to compare the quantitative continuous data between two independent groups, and the One-way Anova test will be used to compare the quantitative continuous data between more than two independent groups. After the Anova test, the Scheffe test will be used as a complementary post-hoc analysis to determine the differences.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnant Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Pregnant women included in the research sample will be divided into two groups as experimental and control groups. Experimental group; is the group to be trained. Control group; It is the group in which no intervention will be made other than data collection.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Experimental group; It is the group that will be given mother and neonatal care education.

Group Type EXPERIMENTAL

Education Group

Intervention Type BEHAVIORAL

Mother care, newborn care and breastfeeding education will be provided to pregnant women in the third trimester of pregnancy.

Control Group

Control group; It is the group in which no intervention will be made other than data collection.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Education Group

Mother care, newborn care and breastfeeding education will be provided to pregnant women in the third trimester of pregnancy.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being at 36-40 weeks of gestation
* Being her first pregnancy
* Being literate
* Being over the age of 18

Exclusion Criteria

* Not in the 36-40 gestational week
* Not a first pregnancy
* Illiterate
* Under 18 years old
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role collaborator

University of Beykent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cisem Bastarcan

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cisem Bastarcan, MsC

Role: PRINCIPAL_INVESTIGATOR

Research Assistant

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beykent University

Büyükçekmece, Istanbul, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CBastarcan

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.